INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2026, Number 3

Cardiovasc Metab Sci 2026; 37 (3)

Characterization of clinical and anatomical profile of patients with anomalous aortic origin of coronary arteries and their association with major cardiovascular outcomes: the experience of a Latin American third-level center

Sánchez-Amaya, David Jacobo; Portillo-Hernández, José Arturo; Godínez-Córdova, Luis Benjamín; Rodríguez-Murillo, Nancy Gabriela; Rivera-Rodríguez, Danny Istayul; Suárez-Lara, Nancy N; Masso-Bueso, Jessy Steve; Gopar-Nieto, Rodrigo; Sierra-Lara Martínez, Jorge Daniel; Posada-Martínez, Edith Liliana

ABSTRACT

Introduction: coronary artery abnormalities are a rare condition but one associated with a potentially serious outcome. Objectives: characterization of clinical and anatomical profiles of patients with Anomalous Aortic Origin of Coronary Arteries (AAOCA) and their association with any pre-specified Major Cardiovascular Events (MACE). Material and methods: a retrospective study was conducted among patients with AAOCA in a tertiary care center, from January 2000 to June 2022. We analyzed the association between clinical and anatomical characteristics of patients and pre-specified MACE (Acute Coronary Syndrome [ACS], surgical revascularization, or cardiovascular death). Results: fifty patients were included. The mean age was 52 ± 15 years, and most patients were male (68%). Systemic hypertension was the most frequent comorbidity (38%). Only five patients (10%) had congenital heart disease. ACS was the most frequent initial clinical presentation (42%). Most AAOCAs affected solely the right coronary artery (60%), and nearly half of all individuals (44%) had at least a high-risk characteristic. MACE was recorded in 14 patients (28%) with a median follow-up of 1,636 days [IQR 626-2,345]. Cumulative probability of MACE was higher in the high-risk group (log-rank p = 0.04). Conclusions: this study highlights the importance of identifying high-risk profiles in such patients, given their association with adverse outcomes.
  FULL TEXT PDF   FLIPBOOK

Keywords

coronary artery anomalies anomalous aortic origin of coronary arteries congenital artery disease high-risk features in coronary artery anomalies major cardiovascular events congenital heart disease




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Ibogaine. A new nightmare for cardiologists in tourist cities?
    2026, Vol.37, Núm. 3
  • Clopidogrel-associated small vessel vasculitis in acute coronary syndrome: a...
    2026, Vol.37, Núm. 3
  • Announcement by ANCAM to all its members regarding the recognition of our...
    2026, Vol.37, Núm. 3
  • Is a meager budget for science and research compatible with a country’s...
    2026, Vol.37, Núm. 3
  • Mobile application to standardize and facilitate invasive hemodynamic...
    2026, Vol.37, Núm. 3
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 37, Num. 3, Julio-Septiembre 2026. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 30 de septiembre de 2026.

 

2026     |     https://www.cardiovascularandmetabolicscience.org.mx/